Abstract. Metastatic progression is the cause of most cancer deaths. Host tumour cell separation (fission) is accompanied by simultaneous acquisition of migrating capability of cancer cells, remodeling of cellular architecture and effective 'homing' in body host environment. Cell remodeling involves cytoskeletal protein-protein and lipid-protein interaction together with altered signaling. Alteration of signaling in tumour cells may affect expression of many genes also by DNAmethylation/demethylation. This would alter the steady-state intracellular level of structural proteins or metabolic enzymes, and notably enzymes involved in the biosynthesis of lipids, affecting the composition of membranes. Lipid rafts are small, heterogeneous, highly dynamic, sterol-and sphingolipidenriched domains that compartmentalize cellular processes. Small rafts can be stabilized to form larger platforms through protein-protein and protein-lipid interactions. Lipid rafts play an important role in intracellular protein transport, membrane fusion and trans-cytosis, also being platforms for cell surface antigens and adhesion molecules which are crucial for cell activation, polarization and signaling. Detachment of individual tumour cells from the host tumour lump requires lipid-protein-lipid raft (LPLR) reordering. Lipid rafts are also involved in angiogenesis and local invasion, which occurs within the host tumour vicinity by exchange of enzymes, cytokines and motility factors that modify the surrounding extracellular matrix (ECM). Many cell surface adhesion, ECM, and signaling proteins (such as E-cadherin, catenin, CD44, MMP-9 and caveolin-1) are known to be absent or reduced following gene promoter-CpG-island hypermethylation in mid-stage growing tumours, but re-expressed (by gene promoterm CpG-DNA demethylation) in carcinomas such as metastasized lung, prostate and sarcomas. The recent research acquisitions on lipid rafts have tremendous implications in understanding the genetic and biochemical bases of metastatic diffusion of cancer.
Introduction
Epigenetic factors and molecular stress imposed by surrounding cell environment may cause imbalance of the intricate cell metabolic network and alter cell cycle regulation, ultimately participating to tumour growth and resistance to apoptosis, whereas a correct regulation of such events maintains health (1, 2) . Lipid rafts (hereafter, rafts) are specialized supramolecular aggregates of sphingolipids (predominantly, sphingomyelin), cholesterol and gangliosides orchestrated by proteins with or without glycosyl-phosphatidyl-inositol (GPI)- Table I . Components of lipid rafts and raft-associated proteins: function and epigenetic regulation mechanism.
-----------------------------------------------------------------------------------------------------
Function/(significant difference in cancer: Components up, ↑; down, ↓; or cancer stage specific, ↑↓) Mechanism of control/regulation Refs. (3) (4) (5) . In recent years researchers have discovered that rafts, besides being important structural components for delivery of lipids and proteins in the body, play important and active roles in membranes fusion, signal transduction and transcytosis (3-10). It has long been known that cancer cells produce more cholesterol and sphingolipids than the normal cell counterparts (11) (12) (13) (14) (15) (16) (17) . Some cancer cells, and particularly those which show the most aggressive phenotype, shed plasma membranes with cholesterol, sphingomyelin and gangliosides. This would allow these aggressive cells to counteract host immune response and escape destruction by the immune system (18, 19) . Furthermore, cells depleted with cholesterol by exogenous agents (drug treatment, pathogens, carcinogens etc.) have been found to disrupt rafts (3, 9, 10) . Here, the epigenetic events associated with biogenesis and molecular orchestration of lipid raft components and their possible role in tumourigenesis will be discussed. The purpose of this review is to highlight raft involvement in tumour growth, angiogenesis, immune escape and metastatic progression of cancer in the general view of their modulation by epigenetic reprogramming (on/off) of the genes coding for raft-associated proteins through sterol regulatory element binding protein (SREBP)-transcription factors. In addition, the role of dynamic flux of methyl layers on DNA at the cytosine-5 C position of promoter-CpG-islands (hereafter, DNA-methylation) will also be discussed to see whether DNA-methylation of certain raft-component genes is responsible for tumour growth and may allow tumour cells to metastasize.

Too many partners for lipid rafts
Interaction of DNA with liposomes (containing synthetic cationic lipids) is well known and gene delivery for gene therapy has been attempted in many different fields on the basis of this knowledge. RNA, at least mRNA, operate in a lipid-membrane environment for protein synthesis; the endoplasmic reticulum (ER). Nevertheless, main components of dynamic assembling of rafts are cholesterol, sphingolipids and ONCOLOGY REPORTS 17: 1279 -1290 Table I. Continued. -----------------------------------------------------------------------------------------------------H-Ras  Energy-dependent signaling  Transcriptional, translational -
proteins, while the presence of nucleic acids is to be excluded to date. These protein and lipid components of rafts have essential functions partially responsible for providing the duplicating cell with the high processivity required to reorganize cellular architecture of the offspring cells through cytokinesis. In the membrane structure, cholesterol is believed to serve as a spacer between the hydrocarbon chains of the sphingolipids, and to function as a dynamic glue that keeps the raft assembly together, having higher affinity to raft sphingolipids than to unsaturated phospholipids. Removal of cholesterol leads to dissociation of most proteins from rafts and renders them non-functional (3) (4) (5) (6) (7) (8) (9) (10) . The existence of rafts was first inferred from the differential trafficking of lipids and lipid-anchored proteins (PLAP-alkaline phosphatase, and HGinfluenza virus hemagglutinin) to the apical macro-domain of polarized epithelial cells (3, 5, 20) , and later experimentally identified by determining with membrane-protein insolubility in cold non-ionic detergent, Triton X-100 (15, (20) (21) (22) (23) . Thus, detection of complex formation with detergent resistant membranes (DRMs) became a useful approach to test whether or not a protein associates with rafts. After dissolving membranes or cells with Triton X-100, Lubrol or CHAPS at 4˚C, raftassociated lipids and proteins remain insoluble, floating to low density by sucrose gradient centrifugation. Biophysical studies have revealed that lipid exists in several phases in the lipid bilayer model, including gel, liquid-ordered and liquiddisordered states, in order of increasing fluidity. In the gel state, lipids are semi-frozen, whereas at the opposite extreme, the liquid-disordered state, the whole lipid bilayer is fluid as proposed by the Singer-Nicholson model (3) (4) (5) (6) (7) (8) (9) (10) 21, 23) . Rafts are first assembled in the Golgi complex in mammalian cells (5, 9, 10) . Cholesterol is synthesized in the ER, as well as ceramide, the hydrophobic backbone of sphingolipids. However, most of the sphingolipid polar-head groups are attached to ceramide in the Golgi complex, where raft assembly takes place (3, 5, 10, 20) . Table I summarizes the components of rafts as identified by detergent insolubility and sucrose gradient centrifugation, immuno-colocalization, and other biophysical methods such as fluorescence resonance energy transfer (FRET) and quantitative high resolution MS spectrometry. The presence of each component cited in Table I in rafts is supported by the experimental work of at least two laboratories, and further confirmed by unbiased proteomics of lipid rafts (24) . This approach yielded a total of 703 proteins, which were identified in detergent-resistant fractions, while 585 were detected in pH carbonate-resistant fractions. Of the 703 detergent-resistant proteins, 392 were quantified and 241 were validated as authentic raft proteins. Identification of such a large set of true raft proteins begs the question of how specific is the assembling of rafts, and what is the connection between raft and signaling (24) . In fact, lipid rafts are often linked to signal transduction pathways, in particular as coordinators of the initial events in the cascades (6).
Lipid rafts and their role in membrane function and intracellular transport
Rafts contain >45.0% cholesterol. Proteins are synthesized, folded in, and transported from the ER, whose membranes have a cholesterol content of <5.0%. Cholesterol and sphingolipid concentration is highest in plasma membrane, and this is apparently achieved by preventing rafts from the retrograde traffic between the Golgi complex and the ER (3-10). Hence, rafts are forwarded from the Golgi complex to the plasma membrane, where they concentrate and spread into the endocytic recycling pathways (3, 4, 25) . Diffusible sterol-binding proteins provide a rapid mechanism for shuttling cholesterol among membranes, allowing the targeted membranes to be depleted, while the vehicle membranes are enriched. Another means to facilitate transport from one membrane to another is the close contact between the two membranes. For example, in many cell types, part of the ER is in close proximity to the plasma membrane (10, 26) , a spatial arrangement that facilitates rapid exchange of compounds due to transfer proteins. Similarly, three-dimensional reconstitution of the Golgi apparatus has revealed extensive areas of close apposition between the cis-Golgi and ER (27) . The sections of the ER close to the endocytic recycling compartment (ERC) and the trans-Golgi are enriched of cholesterol-esterifying enzyme ACAT (28) . This is probably required for allowing efficient delivery of cholesterol to ACAT from these cholesterol-rich membranes. The majority of membranes and cytoskeleton proteins are transported by rafts through trans-Golgi network. However, evidence is accumulating that other modalities of transport are possible, such as the one involving caveolin-1, which forms a complex with chaperon proteins delivering cholesterol from ER to the plasma membrane and bypassing the Golgi apparatus (10,29-31).
Epigenetic mechanisms and cancer
The prefix 'Epi-', meaning 'besides', 'upon' or 'over', implies the existence of other phenomena beyond that indicated by the second part of the word. Epigenetic is the study of the processes by which genotypes give rise to phenotype, including the changes in gene activity occurring during development and differentiation. In addition, it concerns the mitotic inheritance of a given pattern of gene expression (nuclear inheritance) which is not based on differences in DNA sequence, and changes in gene function that are mitotically and/or meiotically heritable and that do not entail a change in DNA sequence (32) . Chemical modifications imposed by environmental signals to the DNA molecule and histone proteins (nucleosome/ chromatin) affect gene function and are collectively termed as epigenetic phenomena. Examples are cytosine methylation, adenine methylation, histone phosphorylation, acetylation, methylation and ubiquitination. Therefore, genetics is the term that refers to inherited genes while epigenetic concerns the regulation of gene activity induced by chemical modification of DNA and chromatin structure proteins. It is now evident that changes occurring in cancer cells, including chromosomal instability, increased propensity to mutation, activation of oncogenes, silencing of tumour suppressor genes, and inactivation of DNA repair systems are events that require the concurrent contribution of genetic and epigenetic abnormalities. Also genomic insulator functions are involved. Insulators are DNA sequences belonging to a class of regulatory elements that define independent domains of gene function, being capable of 'insulating' when complexed with the cognate proteins. Insulator DNAs, or boundary elements, functionally isolate neighboring genes by blocking interactions between distal enhancers and inappropriate target promoters. Many control elements show a broad range of promoter interactions, suggesting that these elements might be affected by inappropriate transcription. In eukaryotes, motifs such as silencers, enhancers and locus control regions act over thousands of base pairs to regulate adjacent genes. The identification of a novel class of directing regulatory elements, called insulators, has provided clues into mechanisms that maintain transcription fidelity of eukaryotic genomes through the organization of independent domains of gene function by restricting enhancer and silencer functions. It is now well-established that boundary elements/insulators function to subdivide eukaryotic chromosomes into autonomous regulatory domains, and one of the underlying mechanisms is that boundaries act as barriers, preventing the processive spreading of 'active' or 'silenced' chromatin between domains. In addition, the partitioning into autonomous functional units is a consequence of an underlying structural subdivision of the chromosome into higher order 'looped' domains. In this view, boundaries are thought to delimit structural domains by interacting with each other or with some other nuclear structure.
The studies reported so far mostly provide support for the looped domain model. Proto-oncogenes and tumour suppressor genes are critical selectable targets for mutation and DNAmethylation in tumours. The readiness at which CpG-sequences undergo alteration affect the shaping of the mutational spectra in tumours along with DNA-methylation spectra (1, 2) . It has been found that >290 of the 393 codons in the p53 gene are mutated in different cancers in one allele, while the other allele is under methylation stress. Human tumours of different histological origins display different patterns of p53 mutation and methylation at CpG-sequences. The most of them are G to T transversion, while fewer are present in skin cancer and involve C to T and CC to TT transition (1, 2) .
The correlation between the status of CpG-island hypermethylation and/or mutation and tumour progression show that, for virtually every tumour type, a precise genetic alteration over time is a major driving force for neoplastic development. However, mutation of specific genes is an inefficient process, because maintenance of genomic integrity is accomplished by a complex array of DNA monitoring and repair enzymes. The genome maintenance protein team strives to ensure that DNA sequence information remains original. Karyotypic order is also guaranteed by other molecular guards, implementing the cell cycle check-points that operate at critical times in the mitotic division. Together, these systems ensure that mutations are rare events, so rare indeed that the multiple mutations known to be present in tumour cells, which are necessary for cancer progression, are low probability events within a human life span (1, 2, 33) . In fact, the most clinically relevant cancers have the tendency to occur more likely in the elderly.
Dynamic flux of methyl layer at the 5'-carbon of cytosine on promoter-CpG-islands of DNA regulates gene function
Among different epigenetic mechanisms regulating gene expression, the most important are believed to be the dynamic methylation at cytosine-5'-carbon of CpG-dinucleotide and histone modifications. Overexpression of DNA (cytosine-5') methyltransferases, responsible for addition of methyl layers on DNA, hypermethylation of CpG-islands at the regulatory regions of certain genes, global hypomethylation, and selective demethylation, are now well known to regulate transcription in association with cell activation and cancer development (34) (35) (36) (37) (38) (39) (40) (41) . The CpG-sites in these gene-associated regions are methylated rarely or demethylated very quickly in normal cells, except in inactivated X-chromosome and imprinted genes, for example (1, (37) (38) (39) (40) . The prevailing view is that methylation of DNA and deacetylation of histones H3 and H4 leads to inactivation/repression, while acetylation of histones H1, H3, H4 and DNA demethylation empowers activation of nucleosomes for transcription of genes (1, (34) (35) (36) (37) . Repression of transcription occurs through the exclusion of proteins that affect chromatin boundaries and prevents transcription factors from binding DNA binding sites. Some proteins, such as MeCP2, MBD1, MBD2, MBD3 and MBD4 selectively bind CpG-and/or methyl-CpG-sequences and remodel nucleosome/chromatin to precipitate it as an inactive complex. This is accompanied by deacetylation of histones upon recruitment of histone deacetylases (HDACs) prior to binding of transcription factors, including RNA polymerase. MBD2 and MBD4 are shown to be associated with DNAdemethylation, but with different mechanisms. MBD2, probably in concert with other unknown protein complexes, removes the -CH 3 group from DNA cytosine, whereas MBD4 removes the whole base (cytosine-5'C-methyl) creating an abasic site, which can be sealed with the help of secondary ligases from the mismatch repair enzyme complex (1, 36, 37) . It is now clear that abnormal methylation of CpG-islands is not only restricted to cultured cells, but it also occurs during ageing and tumour development. While the co-existence of genome-wide hypomethylation and site-selected hypermethylation are well documented by chemical analyses of bases from total genomic DNA in gene specific DNA segment, particularly in promoters, the specific mechanism involving enzymes, co-substrates and repressor proteins is currently being explored (1, 2, (34) (35) (36) (37) (38) 41) . Mutation in several genes encoding chromatin modifying proteins is directly involved in human diseases such as Rett syndrome caused by inactivation of MeCP2 and immunodeficiency-chromosome instability facial anomalies (ICF) syndrome caused by mutations in the de novo DNA methyltransferase DNMT3b. The ATRX gene, which encodes a chromatin-remodeling protein of the SNF2 family and contains a characteristic ATPase/helicase domain, also contains a cystein-rich region similar to domains present in the DNMT3b family. Mutations in this X-linked gene cause mental retardation, urogenital abnormalities, and α-thalassemia caused by down-regulation of the α-globin genes (42-45).
Some raft component genes harbour sterol regulatory elements and CpG-islands
Sterol regulatory element binding proteins (SREBPS), designated as a common family of transcription factors, control cholesterol and fatty acid biosynthetic pathways. SREBPs are membrane bound proteins that, due to the N-terminal active portions, can enter the nucleus to activate their target genes ONCOLOGY REPORTS 17: 1279 -1290 after proteolytic cleavage, which requires sterol sensing molecules such as SREBP-activating protein (SCAP). This mechanism is crucial for sterol activity regulation. SREBPs bind and activate sterol regulatory elements (SREs) within promoters as well as some E-boxes, which makes them eligible to regulate a wide range of lipid metabolism enzymes, and a few genes encoding protein components of rafts. Three isoforms, SREBP-1a, -1c and -2, have different roles in lipid synthesis. In vivo studies using transgenic and knockout mice suggest that SREBP-1 is involved in energy metabolism, including fatty acid and glucose/insulin metabolism, whereas SREBP-2 is specific to cholesterol synthesis (46) (47) (48) . Caveolin-1 has been shown to directly bind cholesterol. In addition, depletion of cellular cholesterol results in the absence of caveolae at the level of plasma membrane (4, 5, (29) (30) (31) . Interestingly, the caveolin-1 promoter has an SRE site and CpG-islands (49, 50) . This is true also in the case of 3-hydroxy-3-methylglutaryl-coenzyme-A-synthase-1 (HMGCS-1), sphingosine acyltransferase, E-cadherin and CD44 (46, (51) (52) (53) (54) (55) . The activity of these genes has been shown to be under direct control of promoter-CpG-cytosine-5'C-methylation/ demethylation flux (50) (51) (52) (53) (54) (55) (56) . Promoters also contain SRE sites (46) (Tables I and II) .
Lipid rafts in immune escape and in new blood vessel formation (neo-angiogenesis)
Actively growing tumour cells need the growth of novel blood vessels to take up nutrients and clean up catabolites for their survival. Neo-formed blood vessels may also become pathways for metastatic diffusion (69, 70) . It has long been known that activated cells shed fragments of their plasma membrane into the extracellular milieu (14, 15, 18, 19, (57) (58) (59) (19) . Extracellular membrane vesicles from tumour cells (EMVTCs), derived from selected areas of plasma membrane (14, 19, 62) , appear to be enriched with raft component cholesterol, GM1, GM3 and sphingomyelin-ceramide, and contain surface antigens and proteases often present in tumour cells (19, (63) (64) (65) (66) (67) . The shed membrane smaller rafts may be aggregated by ceramide, produced locally from sphingomyelin by the action of in situ sphingomyelinase, to form larger domains of EMVTCs (68) . Several studies have suggested that EMVTCs are involved in tumour growth and metastasis by playing relevant roles in the escape of tumours from immune attack and in promoting tumour cell invasion (59, (63) (64) (65) (66) (67) . Surface antigens and immunesuppressing cytokine, such as transforming growth factor (TGF)-ß present in EMVTCs (19) are important factors that protect tumours from immune attack (7, 19, 59, 63) . Several proteases, including matrix metalloproteinases (MMPs) and plasminogen activators, are enriched in EMVTCs/rafts and thought to play a role in tumour cell invasion and metastasis (19, (65) (66) (67) (68) (69) . Endothelial cell migration and invasion through extracellular matrix are essential for neovascularisation, and EMVTCs/rafts enriched with sphingomyelin and MMP-2/ MMP-9 were found capable to increase the process by 3-to 5-fold (19, 66, 67) . EMVTCs promote the formation of capillarylike structures of cells, similar to bFGF (19) . Sphingomyelin, a lipid component of rafts/EMVTCs, stimulated the invasion of endothelial cells without the up-regulation of MMP activity (19) . Tumour cells produce various cytokines and chemokines that attract various leukocytes (neutrophils, eosinophils, macrophages, dendritic cells, and mast cells), as well as lymphocytes, all of which are capable of producing a spectrum of cytokines and cytotoxic mediators including reactive oxygen species, serine and cysteine proteases, MMPs, membrane perforating agents, and soluble mediators of apoptosis, such as tumour necrosis factor (TNF)-α, interleukins and interferons (IFNs) (33, (71) (72) (73) . IFNs are shown to augment DNA-methylation and apoptosis in a number of different cancer cells in vitro, and in tumours in vivo. In addition to altering the local balance of pro-angiogenic factors during melanoma development and in at least human cervical, breast and prostate carcinogenesis, angiogenesis was found to be activated in mid-stage lesions, prior to the appearance of full-blown tumours (33, (69) (70) (71) . One common strategy for shifting the balance involves altered gene transcription. The mechanisms underlying shifts in the balance of the angiogenic regulator are poorly understood. p53 tumour suppressor protein directly regulates thrombospondin-1. Consequently, loss of p53 function, which occurs in most human tumours, can cause thrombospondin-1 levels to fall, liberating endothelial cells from its inhibitory effects (33) . Loss of p53 function has been attributed to mutation in one allele and promoter inactivation by CpG-methylation of the other allele in multiple tumours (1) . The vascular endothelial growth factor (VEGF) is an inducer of angiogenesis and its gene is under multiple complex transcriptional controls, including DNA-methylation. For example, activation of the Ras oncogene, or loss of the Von Hippel Lindau (VHL) tumour suppressor gene in certain cell Table II . Protein components of lipid rafts which are epigenetically regulated in association with multiple cancers.
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types causes up-regulation of VEGF and VEGF-R expression (33, 74, 75) .
We now know that VHL, VEGF and VEGF-R promoter activity is under the direct regulation of DNA-methylation (1, 38, 39, 76) . Ras oncogene induces a general demethylase activity in ras-transfected cells (77) , promoting expression of many genes. It has also been showed that Ras, EGF and VEGF-R proteins are components of rafts (6, 7, 49, 78) . Indeed, further research development will be the systematic study of these kinds of genetic and biochemical signals in individual types of cancer in vitro and in vivo.
Lipid rafts in cell-surface architecture, cell-polarization and chemotaxis
Some types of plasma membrane rafts such as rafts associated with tyrosine-, Src-like kinases and heterotrimeric G-protein subunits have been found to be associated with underlying cytoskeletal structures and may have important implications for signal transduction (3-7). The binding of actin is an important example of interaction of raft components with cytoplasmic proteins, which implies raft-mediated signaling (79) . This interaction is also important for cell surface organization of rafts (80) and mechanical properties of cell membranes (3, 4, 81) . Actin does not bind directly to membranes, but forms protein complexes such as actin-catenin-cadherin (82), actin-(ezrin, radixin, moesin; ERM)-CD44 (80, 83, 122) and many others, depending on tissue and cell types, where catenin and ERM-like proteins constitute a molecular bridge. Also junctional markers such as E-cadherin and CD44 can interact with the neighboring cells through their N-terminal transmembrane domain to form a rigid cell-cell network, i.e., tissue organization of cells.
One of the most striking changes in metastatic carcinoma cells is their dramatic polarization towards blood vessels (84, 85) . When cells polarize and begin to move in response to a chemoattractant, in most cases CD44 is directed to the rear of the cell by an actin-myosin-dependent pathway. The CD44 enriched region coincides with a large area in which lipids are more resistant to extraction by cold Triton X-100 or Lubrol, as observed in neutophils and T-lymphocytes (7, (83) (84) (85) (86) (87) . As the invading cell moves forward through extracellular matrix (ECM) barriers, the leading edge complex of enzymes, inhibitors and receptor molecules cycle continuously through adhesion, de-adhesion and proteolysis (88) . The direction of tumour-cell invasion and migration can be influenced by chemoattractants and by construction of preferred adhesion pathways. Local attractants include: scatter factor/ hepatocyte growth factor (SF/HGF), which binds to the Met receptor (c-Met); proteolised matrix fragments, which are recognized by integrins, cytokines and growth factors such as epidermal growth factor (EGF); and TGF-ß, released from the degraded matrix. The signals are mediated through coupling with their cognate receptors (EGF-R, TGF-R), which also are raft components, and whose gene activity (expression/repression) is tightly regulated by DNA-methylation/demethylation. Cytoskeletal rearrangement, adhesion and de-adhesion are not only required for cellular motility but are also linked to proliferation and pro-survival pathways (33,71,89 ).
Role of rafts in acquisition of metastatic potential
The leading steps of metastasis involve LPLR interactions with ECM for decreasing mechanical stability and increasing shear forces for separation of individual cells from tumour lump. Major behavioral differences between normal and transformed cells are the abundance of collagen fibers in tumours. Several collagen and laminin genes, involved in ECM assembly (Col3a1, Col5a2 and Col6a3, and Lama5 and Lamc2), are over-expressed in tumours and tumour cell lines originating from various adenocarcinomas. The laminins are components of basement membranes that are believed to act as a mechanical barrier against carcinoma cell invasion (71, 85, 89) . Therefore, LPLR remodeling of the ECM, which is confined to the immediate pericellular environment of the cell, seems to be a necessary step in local invasion. The main enzymes that degrade the ECM and cell-adhesion proteins are proteinases such as: i) a family of secreted and membrane raft-anchored MMPs; ii) tissue serine proteinases such as urokinase type plasminogen activator (uPA), thrombin and plasmin (89) . In several experimental models uPA has been shown to function through its receptor (uPAR), which again is a raft component (Table I) . Integrins, tetraspanins, uPAR and rafts conjointly cooperate to confine the serine proteinase uPA to the invading pseudopodia. uPAR is an adhesion receptor for vitronectin, and also interacts with integrin ß-chains. Proteolysis of ECM proteins modifies integrin-mediated anchorage, focal adhesion and cytoskeletal architecture, triggering signaling molecules such as focal adhesion kinase (FAK) and motility factors such as AMF/PHI. Remarkably, it has been shown that MMP and uPAR gene activity is directly controlled by DNA-methylation and demethylation of their respective CpG-island-rich promoters at cytosine-5'-carbon. Moreover, MMPs and uPAR are components of rafts (90-94).
Conclusion and perspectives
Many proteins involved in important processes including signal transduction and structural components are assembled in rafts. As a consequence of their interaction with rafts, several cell surface enzymes and marker proteins show an increase in catalytic efficiency and in/out transport of molecules, and signal transduction across membranes is activated (3) (4) (5) (6) (7) (95) (96) (97) . Thus, rafts might play a coordinating role for these phenomena. Interestingly, most of these enzymes/proteins either recognize specific antigens or have limited signal transduction specificity. An intriguing possibility is that raft-integrated proteins, for which changes in structure-function after binding with other molecules are essential steps for their action, use rafts to interact with their cognate components (3) (4) (5) (6) (7) (8) (9) (57) (58) (59) (60) (61) (62) (63) (64) (65) (66) (67) (68) (69) (70) (71) (72) (73) (74) (75) (78) (79) (80) (81) (82) (83) (84) (85) (86) (87) (88) . In a similar way, rafts appear to be able to facilitate transportation of cell junction proteins from cytosol to membranes. Raft trafficking seems to be a way for the cell to recruit and transport proteins to a particular place at a particular moment of cell life (5, 7, (79) (80) (81) (82) (83) (84) (85) (86) (87) (88) . Studies have shown that cholesterol, sphingolipids and gangliosides, all raft components, are up-regulated in aggressive metastasized tumours in comparison to benign tumours at early stage (11) (12) (13) (14) (15) (16) (17) (18) 57, 58, 60, 61, 62, 63, (65) (66) (67) (68) . In many cases it has been shown that the level of expression of cell adhesion molecules and metastasis protein factors ONCOLOGY REPORTS 17: 1279 -1290 associated with rafts are differently regulated in growing, progressing and metastasizing tumours. These genes are mostly inactivated by DNA-methylation (Table II) (1, (36) (37) (38) (39) (40) (41) . For instance, mRNA and protein expression of caveolin-1, a major component of caveolae proteins, is frequently lost in multiple cancers. Caveolin-1 is known to be a tumour suppressor gene. Current results are consistent with the dual function of caveolin-1 both as a tumour suppressor gene and metastasis-promoting gene. At cancer onset, the calveolin-1 gene is repressed by DNA-methylation, while re-expression by demethylation occurs prior to metastasis (50, 56, 108) . CD44 associated to lipid rafts is known to be involved in re-organization of highly dynamic structures of cytoskeleton when cells respond to extracellular stimuli by division and/or changes in shape or activity (83) . mRNA and protein expression of CD44 is frequently lost by DNA-methylation in multiple cancers at the early stage of tumour progression (36, 51, 53, 55, (99) (100) (101) . Again, re-expression of the CD44 gene is necessary for metastatic diffusion of many tumours (52, 98, 100, 101, 109, 111) . E-cadherin transmembrane glycoprotein is a calcium-dependent cell-cell adhesion molecule, known to play a key role in the maintenance of tissue integrity by forming a complex with catenin. E-cadherin is eventually tagged to actin cytoskeleton through catenins. Because loss of E-cadherin expression results in disruption of cellular clusters, it has been postulated that E-cadherin functions as a tumour suppressor gene. mRNA and protein expression of E-cadherin is frequently lost by DNA-methylation in multiple cancers at the early stage of tumour progression (36, 54, 82, (101) (102) (103) (104) (105) (106) (107) 110, 117) . Also in this case, re-expression of E-cadherin has been shown to be clinically significant at the metastatic foci of many cancers (101, 103, (105) (106) (107) . Persistent expression of E-cadherin was observed in breast cancer (71, 102) .
The most damaging change during cancer progression is the switch from a locally growing tumour to a metastatic killer (112) . This involves many steps in which lipids are integral components of molecular structures allowing biochemical interactions with proteins and enzymes. A list of phenomena in which protein-lipid interaction are fundamental include environmental threats such as oncogene activation and proliferation of transformed cells, acquired ability of protection against the immune system, release of angiogenic factors, local invasion and destruction of extracellular matrix, detachment and migration from the tumour lump and penetration through the blood vessel wall, arrest of the cells in the lumen of small blood vessels or lymphatics, and docking and formation of fusion clump to distant organs by reverse penetration of blood vessels (33) . Rafts are platforms for cell surface antigens and adhesion molecules. Accordingly, they play crucial roles in cancer cell polarization and signaling. For instance, a recent review (126) focused on cholesterol-rich membrane rafts as potential sites of processing of non-genomic signals that involve androgen as well as other classical steroid receptors (SRs). However, although the molecular details as well as the biological meaning of non-genomic action of steroids are still investigated and debatable, the familiar loss of control of receptors such as androgen receptor (AR) and estrogen receptor is a clinically relevant priority area of investigation. The main molecular target for testosterone is AR, which is a member of the nuclear receptor family of ligand-induced transcription factors. It binds to a specific chromatin region bearing androgen responsive elements (ARE) in concert with other transcriptional regulators, and controlling the transcription of target genes (126) . The activation of SRs was thought to be dependent on the availability of the specific ligand (hormone), but subsequent data on DNA-methylation of the target gene promoter have added new insights into the steroid function in cancer progression (127) (128) (129) .
It has been shown that lovastatin (an inhibitor of cholesterol biosynthesis) inhibits mammary carcinoma metastasis and that cyclodextrin (which can efflux cholesterol from cells and membranes) decreases apical transport of raft-associated proteins, while latrunculin-B disrupts actin cytoskeleton (hence raft redistribution is deregulated), thus preventing the activated T-cell polarity. All this indicates that gangliosidecholesterol-rafts play definite roles in the above cellular processes (88, 108, (112) (113) (114) 115) . For instance, metastatic potential of mouse Lewis lung cancer cells is regulated via ganglioside GM1 by modulating the MMP-9 localization in rafts. Among adhesion molecules, only integrin ß1 was detected in glycolipid-enriched microdomain (GEM)/rafts with stronger intensity in highly metastatic cell lines and low staining in GM1-expressing cells. Taken together, integrins may very likely be enriched in GEM/rafts in which GM1 levels are decreased. As a consequence, MMP-9 is recruited to the GEM/rafts, resulting in efficient secretion and activation, and eventually facilitating invasion and metastatic potentials (130) . In this context, accumulation of lipids and cholesterol in solid tumours, including prostate cancer has been observed (11, 96, 126, 131) . It must be pointed out that blood cholesterol is a major source of plasma membrane cholesterol as a result of cellular absorption of lipoprotein from serum, thus membrane cholesterol content is substantially dependent on diet (131) . It is known that rates of prostate and other cancers are significantly affected by exogenous factors, including the western diet that implies consumption of red meat and/or excessive animal fat (132) , whereas reduced intake of animal fat and red meat along with consumption of poly-phenolic compounds (curcumin from turmeric, catechins from green tea, and many others like zinger, cumin, neem, aswagandha, that have all been found to reduce cholesterol), besides other molecular reasons still to be investigated, are considered important for prevention of cancer progression and currently tested in in vivo animal models or clinically (11, 126, (132) (133) (134) . Many raft component genes are epigenetically regulated by dynamic flux of methyl layer at cytosine-5'C of promoterCpG-islands of DNA. CpG-island methylation is one of many epigenetic switches, and plays critical roles in controlling expression of raft proteins involved in tumour growth and cancer metastasis. Treatment of cells with histone deacetylase inhibitor trichostatin A was found capable of enhancing lipid rafts (135) . This is direct proof of epigenetic modulation of raft components. Since the raft component proteins play their role by association-dissociation with rafts, targeting lipids such as cholesterol or sphingomyelin along with proteins might be the new frontier for novel therapeutic intervention for cancer.
